DTL
RNAC icon

Dynamic Technology Lab’s Cartesian Therapeutics RNAC Stock Holding History

Dynamic Technology Lab’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-416
Closed -$52K – 1414
2021
Q2 		$52K Buy
+416
New +$49.5K 0.01% 1066
2021
Q1 		– Sell
-485
Closed -$44K – 1441
2020
Q4 		$44K Buy
+485
New +$42.1K 0.01% 932
2020
Q2 		– Sell
-908
Closed -$66K – 1286
2020
Q1 		$66K Buy
+908
New +$87.7K 0.01% 925

Other funds holding RNAC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's RNAC Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Cartesian Therapeutics (RNAC) in Q3 2021, closing a stake of 416 shares — an estimated $52K sold.

Dynamic Technology Lab first reported a position in RNAC in Q1 2020 and held it in 3 quarters. The position peaked at $66K in Q1 2020. 103 funds tracked by Wall St. Rank hold RNAC as of Q3 2021.

  • Dynamic Technology Lab reported no remaining Cartesian Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 416 Cartesian Therapeutics shares in Q3 2021, an estimated $52K.
  • Dynamic Technology Lab first reported a position in Cartesian Therapeutics in Q1 2020 and held it in 3 quarters.
  • Dynamic Technology Lab's Cartesian Therapeutics position peaked at $66K in Q1 2020.
  • 103 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.